Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc., as indicated in the metadata) on August 9, 2007. The report serves to announce the financial results for the company's first fiscal quarter ended June 30, 2007. The full details of these results are contained in a press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), the content of which is not present in the source text.
Material Changes
The filing text does not provide specific data to compare current period results against prior comparable periods. No material changes in financial condition or operations are quantified in the body of this 8-K.
Guidance, Outlook, and Risks
The filing does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document strictly functions as a notification that the Q1 2007 results have been issued via a press release.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net loss, cash position) by reviewing the full text of the press release dated August 9, 2007 (Exhibit 99.1).
- Confirm the discrepancy between the metadata company name ("Sonoma Pharmaceuticals, Inc.") and the registrant name in the filing ("Oculus Innovative Sciences, Inc.").
- Review the press release for any specific operational updates or product milestones associated with the Q1 2007 period.